imugene-investor-presentations-asx.jpg

Control Your Narrative.

Digital Marketing

IR Social Media Management & Strategy

AI Growth Strategies

Web Design

Media Relations

Experience Matters ↓

Experience Matters

  • Imugene ASX: IMU

    We have been working with Team Imugene since 2018, where we commenced work on rebranding, new website development, social media management and marketing communications consulting.

    “I don’t think of Bradley as a consultant but more as an extension and collaborator of Imugene. He understands the message and has helped me develop the culture and executes on the vision of Imugene. I really appreciate his innovative approach to everything we do and his contagious energy. He is super perceptive at conveying the company’s message and sets the right tone for our social presence. I am forever thankful to have such a bright, talented and energetic team member of Imugene at the helm of our social media.”

    - CEO, Leslie Chong

  • Arovella Therapeutics ASX: ALA

    Working closely with the CEO, we orchestrated a re-branding from SUDA to Arovella to better align with the company’s strategic goals and advancements into iNKT technologies. Tasks included new name, logo, website, branding and social media management. (Previously ASX: SUD)

    “We have been working with Bradley for several years. He has led our social media activities, and more recently, he has worked with us for a complete re-branding and website re-development. It’s refreshing to have someone that understands everything from our website to our social media activities. Bradley is an excellent operator and a pleasure to work with. He brings a unique layer of creativity and constantly searches for more effective ways to integrate our messaging to enhance our brand awareness. With his experience, Bradley is confident to take charge, and he continuously offers excellent suggestions to build our online presence.”

    - CEO, Dr Michael Baker

    “In October last year Suda changed its name to Arovella (ASX:ALA), which derives from arrow (as in targeted drug delivery) and novel (as in novel therapies). Whatever the derivation, it’s a nice name that rolls off the tongue.”

    - Dr Boreham’s Crucible, STOCKHEAD

  • Radiopharm Theranostics ASX: RAD

    A new ASX listed biotech focused on the development of radiopharmaceutical products for diagnostic and therapeutic uses. We provide social media management strategy pre-and-post IPO.

  • Chimeric Therapeutics ASX: CHM

    A new ASX listed biotech company focused on cell therapy. We provide social media management strategy pre-and-post IPO.

  • Prescient Therapeutics ASX: PTX

    PTX is a drug development biotech focused on new cancer drugs. Consulting included social media management, marketing, video production and investment outreach in Sydney and Melbourne.

  • Enero ASX: EGG

    Enero Group is an international group of marketing and communications firm with over 600 staff. Consulting included strategic marketing and new business development.